Addex Therapeutics (ADXN)
(Delayed Data from NSDQ)
$8.13 USD
+0.03 (0.37%)
Updated Aug 4, 2025 10:00 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Addex Therapeutics Ltd. Sponsored ADR has a market cap of $8.61M, which represents its share price of $8.13 multiplied by its outstanding shares number of 1.06M. As a small-cap company, ADXN's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ADXN 8.13 +0.03(0.37%)
Will ADXN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ADXN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADXN
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year?
ADXN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates
Catalyst Pharmaceutical (CPRX) Tops Q3 Earnings and Revenue Estimates
Are Medical Stocks Lagging Boston Scientific (BSX) This Year?
Other News for ADXN
Addex Therapeutics (ADXN) Invests in Stalicla's Autism Drug Development
Stalicla secures CHF 2M investment led by Addex for neuropsychiatric drug development
Addex Therapeutics Secures Shareholder Approval at 2025 AGM
Trading Resumes for Addex Therapeutics (ADXN) | ADXN Stock News
Addex Therapeutics Ltd – ADR trading resumes